Information about Bencis IV Continuation Fund GP
My details
*
*
*

Bencis IV Continuation Fund GP (SRL)

KvK 88969444

Strawinskylaan 1577, 1077 XX Amsterdam

Company information

Status
Active

KVK number

KvK 88969444

VAT Number

NL 864839170 B01
Established
18-01-2023
Last balance sheet year
2024
Company size
Micro 0 FTE
RSIN number
864839170
Principal activity
Activiteiten van financiële holdings
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Bencis IV Continuation Fund GP

2024 2023
Equity € 15.625 -7 % € 16.830
Employees 0 0

Frequently asked questions

What is the KVK number of Bencis IV Continuation Fund GP?
The KVK number of Bencis IV Continuation Fund GP is KvK 88969444
What is the VAT number of Bencis IV Continuation Fund GP?
The VAT number of Bencis IV Continuation Fund GP is NL 864839170 B01.
Wat is the PEPPOL ID of Bencis IV Continuation Fund GP?
There is no information available about the PEPPOL ID of Bencis IV Continuation Fund GP or the company is not yet registered on the PEPPOL network.
When was Bencis IV Continuation Fund GP founded?
Bencis IV Continuation Fund GP was founded on 18-01-2023.
What is the address of Bencis IV Continuation Fund GP?
The current registered office of Bencis IV Continuation Fund GP is located at Strawinskylaan 1577, 1077 XX Amsterdam.
When was the last time Bencis IV Continuation Fund GP filed their annual financial statements?
The most recent financial statements of Bencis IV Continuation Fund GP were filed on 31-12-2024.
How many employees does Bencis IV Continuation Fund GP have?
There are currently no employees working at Bencis IV Continuation Fund GP or no workforce information is available.
What is the annual turnover of Bencis IV Continuation Fund GP?
There is no turnover available for Bencis IV Continuation Fund GP.

Sources